ALUR ALLURION TECHNOLOGIES, INC.

NYSE


$ 2.05 $ -0.03 (-1.49 %)    

Tuesday, 21-Oct-2025 17:59:31 EDT
QQQ $ 610.29 $ -0.16 (-0.03 %)
DIA $ 469.10 $ 2.20 (0.47 %)
SPY $ 670.98 $ -0.01 (0 %)
TLT $ 91.99 $ 0.45 (0.49 %)
GLD $ 376.61 $ -25.91 (-6.43 %)
$ 1.99
$ 1.95
$ 1.93 x 5
$ 2.05 x 49
$ 1.95 - $ 2.03
$ 1.93 - $ 20.00
24,866
na
128.33M
$ 2.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-26-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 10-20-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 allurion-highlights-peer-reviewed-publication-on-consecutive-use-of-allurion-smart-capsule

Multicenter study across six countries demonstrates safety and efficacy of two consecutive treatments in adults with obesityWei...

 watching-allurion-technologies-shares-see-volume-to-the-upside-traders-circulate-x-post-saying-new-publication-in-the-obesity-surgery-journal-about-the-allurion-swallowable-gastric-balloon-program-titled-weight-loss-maintenance-1-year-after-the-swallowable-gastric-balloon-results-from-an-international-multicenter-study

https://link.springer.com/article/10.1007/s11695-025-08074-2

 allurion-technologies-presents-study-on-increasing-muscle-mass-and-decreasing-fat-mass-in-patients-treated-with-allurion-program-at-soffcomm

In 1,962 patients treated in France with the Allurion Program, muscle mass as a percentage of total body weight increased, on a...

 allurion-technologies-q1-adj-eps-024-beats-858-estimate-sales-558m-beat-550m-estimate

Allurion Technologies (NYSE:ALUR) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION